Provided are compounds of Formula I and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
申请公布号
WO2013185093(A1)
申请公布日期
2013.12.12
申请号
WO2013US44812
申请日期
2013.06.07
申请人
GILEAD SCIENCES, INC.;SELCIA LIMITED
发明人
STEADMAN, VICTORIA ALEXANDRA;POULLENNEC, KARINE G.;LAZARIDES, LINOS;ACIRO, CAROLINE;DEAN, DAVID KENNETH;KEATS, ANDREW JOHN;SIEGEL, DUSTIN SCOTT;SCHRIER, ADAM JAMES;MACKMAN, RICHARD;JANSA, PETR